World Journal of Gastrointestinal Oncology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 1771585

Number of visits today: 374

Number of downloads: 1282842

INDEXING/ABSTRACTING

MEMBERSHIP

BPG JOURNALS

About the Journal

Name of Journal	World Journal of Gastrointestinal Oncology
Title Abbreviation	World J Gastrointest Oncol
ISSN	1948-5204 (online)
DOI	10.4251
Background	World Journal of Gastrointestinal Oncology (WJGO, World J Gastrointest Oncol) is a high-quality, online, open-access, single-blind peer-reviewed journal published by the Baishideng Publishing Group (BPG). WJGO accepts both solicited and unsolicited manuscripts. Articles published in WJGO are high-quality, basic and clinical, influential research articles by established academic authors as well as new researchers. The paramount objective of WJGO is to showcase and promote distinguished research in the field of gastrointestinal oncology, to help advance development of this field. The types of articles published in the WJGO include Editorial, Opinion Review, Frontier, Review, Minireview, Basic Study, Clinical Research, Systematic Review, Meta-analysis, Evidence-based Medicine, Field of Vision, Clinical Guidelines, Letter to the Editor, and Case Report.
Aim	The primary aim of WJGO is to provide scholars and readers from various fields of gastrointestinal oncology with a platform to publish high-quality basic and clinical research articles and communicate their research findings online. In order to ensure the quality, timeliness, fairness, and transparency of publication, WJGO has implemented a variety of measures as follows: First, authors must prepare their articles according to the appropriate international publication recommendations, including the STROBE Statement, CONSORT 2010 Statement, PRISMA 2009 Checklist, and CARE Checklist – 2016: Information for writing a case report. Second, articles published in WJGO must undergo rigorous cross-international peer review. WJGO peer reviewers come from different countries, chosen independently by artificial intelligence technique or our editorial office, and not by the authors, to ensure fairness and integrity of the peer review. Third, designation of co-first authors and/or co-corresponding authors is not permitted. Fourth, WJGO accepts a manuscript for publication based on its novelty, innovativeness, data accuracy, image reliability, clear language expression, and ethical requirements. Of note, peer reviewers are advised to complete their peer review within 7 days, providing a comprehensive evaluation of the scientific and linguistic quality of the manuscript. Fifth, BPG adopts a 7-day publishing management policy. This means that each step of the publishing process, including manuscript preview, peer review, manuscript revision by authors, final acceptance, language editing, and production, and release, must be completed within 7 days. Finally, the peer review report, author’s response to the peer review report, biostatistics review certificate, copyright license agreement, institutional ethics committee approval document, informed consent document(s), conflict-of-interest statement, CrossCheck detection report, authors’ personal ORCID numbers, funding information, language editing certificate, and other relevant documents will be published online along with the article to allow for an open and transparent publishing process.
Scope	WJGO mainly publishes articles reporting research results obtained in the field of gastrointestinal oncology and covering a wide range of topics, including islet cell adenoma, liver cell adenoma, adenomatous polyposis coli, appendiceal neoplasms, bile duct neoplasms, biliary tract neoplasms, hepatocellular carcinoma, islet cell carcinoma, pancreatic ductal carcinoma, cecal neoplasms, colonic neoplasms, colorectal neoplasms, hereditary nonpolyposis colorectal neoplasms, common bile duct neoplasms, duodenal neoplasms, esophageal neoplasms, gallbladder neoplasms, Gardner syndrome, gastrinoma, gastrointestinal neoplasms, glucagonoma, ileal neoplasms, insulinoma, intestinal neoplasms, jejunal neoplasms, liver neoplasms, experimental liver neoplasms, pancreatic neoplasms, peritoneal neoplasms, rectal neoplasms, sigmoid neoplasms, somatostatinoma, stomach neoplasms, and vipoma.
Open Access	Open access
Indexing/Abstracting	The WJGO is now abstracted and indexed in PubMed, PubMed Central, Science Citation Index Expanded (SCIE, also known as SciSearch®), Journal Citation Reports/Science Edition, Scopus, Reference Citation Analysis, China National Knowledge Infrastructure, China Science and Technology Journal Database, and Superstar Journals Database.
Journal Metrics	The 2023 edition of Journal Citation Reports® cites the 2022 impact factor (IF) for WJGO as 3.0; IF without journal self cites: 2.9; 5-year IF: 3.0; Journal Citation Indicator: 0.49; Ranking: 157 among 241 journals in oncology; Quartile category: Q3; Ranking: 58 among 93 journals in gastroenterology and hepatology; and Quartile category: Q3. The WJGO’s CiteScore for 2022 is 4.1 and Scopus CiteScore rank 2022: Gastroenterology is 71/149; Oncology is 197/366.
Article Processing Charge	Article processing charge
Editors-in-Chief	Monjur Ahmed, Florin Burada
Publisher	Publisher
Research Domain	Gastroenterology and Hepatology
Article Reprints	Article reprints
Permissions	Permissions
Help Desk	Help desk
Special Statement	Special statement
Copyright ©	© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Contact Us	Contact us